Clinical Trials Browser

Esophageal Squamous Cell Carcinoma

Carcinoma, Renal Cell

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

Triple Negative Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Endometrial Neoplasms

Head and Neck Neoplasms

Small Cell Lung Carcinoma

Nasopharyngeal Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Ovarian Neoplasms

Triple Negative Breast Neoplasms

Nasopharyngeal Carcinoma

Oropharyngeal Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms

Breast Neoplasms

Locally Advanced Rectal Cancer

Triple Negative Breast Neoplasms

Nasopharyngeal Carcinoma

Carcinoma, Transitional Cell

Triple Negative Breast Neoplasms

Nasopharyngeal Carcinoma, Recurrence

Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)

Turcot syndrome, Colorectal Neoplasms

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Advanced Solid Tumor

Colonic Neoplasms

Carcinoma, Renal Cell

Malignant Neoplasms of Digestive Organs

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

Solid Tumor, Adult

Triple Negative Breast Neoplasms

Breast Neoplasms

Stage IB-IIIB NSCLC

Squamous Cell Carcinoma of Head and Neck, Neoplasms

Squamous Cell Carcinoma of Head and Neck

Advanced Solid Tumors

Nasopharyngeal Carcinoma

Pancreatic Cancer Metastatic

Sinonasal undifferentiated carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Paranasal Sinus Neoplasms

Nasopharyngeal Carcinoma

Triple Negative Breast Neoplasms

Pancreatic Neoplasms

Nasopharyngeal Carcinoma

Breast Neoplasms

Cholangiocarcinoma

Clinical Trials

A Study of KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy as First-line Treatment in Patients With Advanced Esophageal Cancer

Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma

The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer

(NeoScorch HN)

NEOTRIO-2

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers

A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

TRANSPARENT

A Study of CHS-114 in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC

IPROC

A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer

Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)

Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer

A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.

A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)

TORCH-iTNT

Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)

Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial

9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer

A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer

A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.

LungTime-C02

PICC

DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer

A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer

A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours

Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC

A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study

A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)

Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Non-small Cell Lung Cancer With or Without Prior Neoadjuvant Therapy

Study of CHS-114 in Participants With Advanced Solid Tumors

Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC

A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer

Toripalimab With Chemotherapy for Sinus Cancer

Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies

Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration

Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors

TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma

NeoHunter

Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study